Evidence map›Paper›PMID 38516597›Full record

ArticleRSC medicinal chemistry2024

Stereoselective synthesis and antiproliferative activity of

Zein Alabdeen Khdar, Tam Minh Le, Zsuzsanna Schelz, István Zupkó, Zsolt Szakonyi

Open access · hybridAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Stereoselective Synthesis and Antimicrobial Studies ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Gibberellic Acid (GAChemistry & biodiversity · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zein Alabdeen KhdarInstitute of Pharmaceutical Chemistry, University of Szeged Eötvös utca 6 H-6720 Szeged Hungary szakonyi.zsolt@szte.hu +36 62 545705 +36 62 546809.
Tam Minh LeInstitute of Pharmaceutical Chemistry, University of Szeged Eötvös utca 6 H-6720 Szeged Hungary szakonyi.zsolt@szte.hu +36 62 545705 +36 62 546809.
Zsuzsanna SchelzInstitute of Pharmacodynamics and Biopharmacy, University of Szeged H-6720 Szeged Hungary.ORCID https://orcid.org/0000-0002-8519-4830
István ZupkóInstitute of Pharmacodynamics and Biopharmacy, University of Szeged H-6720 Szeged Hungary.
Zsolt SzakonyiInstitute of Pharmaceutical Chemistry, University of Szeged Eötvös utca 6 H-6720 Szeged Hungary szakonyi.zsolt@szte.hu +36 62 545705 +36 62 546809.ORCID https://orcid.org/0000-0003-2432-8409
University of Szeged · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new library of

Identifiers

PMID38516597
PMCPMC10953481
OpenAlexW4391758805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.